These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 343146)

  • 1. A double-blind investigation of piracetam (nootropil) versus placebo in the memory of geriatric inpatients.
    Abuzzahab FS; Merwin GE; Zimmermann RL; Sherman MC
    Psychopharmacol Bull; 1978 Jan; 14(1):23-5. PubMed ID: 343146
    [No Abstract]   [Full Text] [Related]  

  • 2. [Nootropic drugs: effects and effectiveness. A reflection exemplified by a phase III study using piracetam].
    Herrmann WM; Kern U
    Nervenarzt; 1987 Jun; 58(6):358-64. PubMed ID: 3302738
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effectiveness of piracetam in tardive dyskinesia - double-blind cross-over controlled trial with a placebo].
    Kabes J; Sikora J; Starý O; Pisvejc J; Hanzlícek L
    Cesk Psychiatr; 1983 Oct; 79(5):339-45. PubMed ID: 6357509
    [No Abstract]   [Full Text] [Related]  

  • 4. The efficacy of piracetam in vertigo. A double-blind study in patients with vertigo of central origin.
    Oosterveld WJ
    Arzneimittelforschung; 1980; 30(11):1947-9. PubMed ID: 7006617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical experience with treatment by piracetam in gerontopsychiatry (author's transl)].
    Vencovský E; Hronek J; Drahokoupil L; Fait V; Hudcová T; Laciga Z; Vanková H
    Cesk Psychiatr; 1980 Apr; 76(2):89-97. PubMed ID: 6994907
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of piracetam on the brain-organic psychosyndrome in cerebrovascular insufficiency. Results of a double-blind study in 40 cases].
    Trabant R; Poljakovic Z; Trabant D
    Ther Ggw; 1977 Aug; 116(8):1504-21. PubMed ID: 331549
    [No Abstract]   [Full Text] [Related]  

  • 7. A double blind investigation of piracetam (Nootropil) vs placebo in geriatric memory.
    Abuzzahab FS; Merwin GE; Zimmermann RL; Sherman MC
    Pharmakopsychiatr Neuropsychopharmakol; 1977 Mar; 10(2):49-56. PubMed ID: 360232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cognitive function in alcoholics in a double-blind study of piracetam].
    Buranji I; Skocilić Z; Kozarić-Kovacić D
    Lijec Vjesn; 1990; 112(3-4):111-4. PubMed ID: 2204773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [On the dose-effect relationship in the therapy with piracetam (author's transl)].
    Kretschmar JH; Kretschmar CH
    Arzneimittelforschung; 1976; 26(6):1158-9. PubMed ID: 786310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind, placebo-controlled study of piracetam in elderly psychiatric patients [proceedings].
    Chouinard G; Annable L; Ross-Chouinard A; Olivier M; Fontaine F
    Psychopharmacol Bull; 1981 Jan; 17(1):129. PubMed ID: 7232645
    [No Abstract]   [Full Text] [Related]  

  • 11. A controlled clinical trial on the effect of piracetam in epileptic children.
    Kunneke PS; Malan GM
    Br J Clin Pract; 1979 Sep; 33(9):266-71. PubMed ID: 385029
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of vertigo syndrome with Nootropil].
    Miszke A; Rapacz K
    Otolaryngol Pol; 1988; 42(5):312-7. PubMed ID: 3075732
    [No Abstract]   [Full Text] [Related]  

  • 13. [Management of neuroleptic side-effects with piracetam (author's transl)].
    Sikora J; Kabes J; Pisvejc J
    Cesk Psychiatr; 1981 Apr; 77(2):137-42. PubMed ID: 6114800
    [No Abstract]   [Full Text] [Related]  

  • 14. A double blind trial of piracetam (UCB 6215) and placebo in cases of post-ECT cognitive deficiency.
    Bagadia VN; Gada MT; Mundra VK; Simon S; Doshi JM; Pradhan PV; Shah LP; Sheth UK
    J Postgrad Med; 1980 Apr; 26(2):116-20. PubMed ID: 7012328
    [No Abstract]   [Full Text] [Related]  

  • 15. [Piracetam in the treatment of soft tissue rheumatism].
    Glas-Schöttl R
    Fortschr Med; 1989 Apr; 107(13):298-302. PubMed ID: 2656442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Piracetam and dyslexia: effects on reading tests.
    Wilsher CR; Bennett D; Chase CH; Conners CK; DiIanni M; Feagans L; Hanvik LJ; Helfgott E; Koplewicz H; Overby P
    J Clin Psychopharmacol; 1987 Aug; 7(4):230-7. PubMed ID: 3305591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trial of piracetam in disorders of consciousness due to head injury.
    Calliauw L; Marchau M
    Acta Anaesthesiol Belg; 1975 Apr; 26(1):51-60. PubMed ID: 773078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experience using nootropil in patients with chronic ischemic heart disease].
    Shubina TI; Zaĭtsev VP
    Klin Med (Mosk); 1989 May; 67(5):36-8. PubMed ID: 2671485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Piracetam in the treatment of alcohol-induced delirium].
    Snel H; Lehmann E; Velikonja M
    MMW Munch Med Wochenschr; 1983 Oct; 125(42):947-9. PubMed ID: 6417503
    [No Abstract]   [Full Text] [Related]  

  • 20. [Drug therapy of Alzheimer's disease. Problems of the criteria of clinical trials of nootropic drugs].
    Hirai S
    Nihon Rinsho; 1988 Jul; 46(7):1592-9. PubMed ID: 3221466
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.